Articles

Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial

Internal, Vascular and Emergency Medicine - Stroke Unit, University of Perugia, Perugia
Klinikum Darmstadt GmbH, Darmstadt
Internal, Vascular and Emergency Medicine - Stroke Unit, University of Perugia, Perugia
Service de Medecine Vasculaire et Therapeutique, CHU de St-Etienne, Saint-Etienne
Department of Haematology, St. Thomas' Hospital, King's College London
Brigham and Women’s Hospital/Hematology Division, Harvard Medical School, Boston
Clinical Research Department, FADOI Foundation, Milan, Italy 6 Internal Medicine Department, Fatebenefratelli Foundation, San Giovanni Calibita Fatebenefratelli Hospital,, Rome
Hospital Puerta de Hierro, Madrid
Institute of Hematology and BMT Rambam Health Care Campus Technion, Israel Institute of Technology Haifa
Internal, Vascular and Emergency Medicine - Stroke Unit, University of Perugia, Perugia
Haematologica Early view Aug 12, 2021 https://doi.org/10.3324/haematol.2021.279072